Therapeutic use of stem cells in horses: Which type, how, and when?

Veterinary Journal

Volumn 197, Issue 3, 2013, Pages 570-577

  Schnabel, Lauren V ^a   Fortier, Lisa A ^a   Wayne McIlwraith, C ^b   Nobert, Karl M ^c  

^a Animal Health Diagnostic Center   (United States)

^b Department of Environmental and Radiological Health Sciences   (United States)

^c Squire Sanders (US) LLP   (United States)

Author keywords

Equine musculoskeletal disorders; FDA; Osteoarthritis; Stem cells; Tendonitis

Indexed keywords

ADIPOSE DERIVED STEM CELL; ALLOGENEIC STEM CELL TRANSPLANTATION; AWARENESS; BONE MARROW BIOPSY; BONE MARROW CONCENTRATE; CELL TYPE; COMMERCIAL PHENOMENA; FLEXOR TENDON; GOVERNMENT REGULATION; HEMATOLOGICAL PROCEDURE; HEMATOPOIETIC STEM CELL; HORSE; MEDICAL INFORMATION; MEDICAL PRACTICE; MESENCHYMAL STEM CELL; MUSCULOSKELETAL DISEASE; NONHUMAN; OSTEOARTHRITIS; PROFESSIONAL KNOWLEDGE; REGENERATIVE MEDICINE; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; STEM CELL; STEM CELL TRANSPLANTATION; STERNUM; SURGICAL TECHNIQUE; TENDINITIS; TREATMENT INDICATION; TREATMENT PLANNING; VETERINARIAN; VETERINARY MEDICINE;

EQUIDAE;

EQUINE MUSCULOSKELETAL DISORDERS; FDA; OSTEOARTHRITIS; STEM CELLS; TENDONITIS;

ANIMALS; HORSE DISEASES; HORSES; STEM CELL TRANSPLANTATION;

EID: 84884974771     PISSN: 10900233     EISSN: 15322971     Source Type: Journal    
DOI: 10.1016/j.tvjl.2013.04.018     Document Type: Review

References (48)

1. Adams M.K., Goodrich L.R., Rao S., Olea-Popelka F., Phillips N., Kisiday J.D., McIlwraith C.W. Equine bone marrow-derived mesenchymal stromal cells (BMDMSCs) from the ilium and sternum: Are there differences?. Equine Veterinary Journal 2012, 45:372-375.
2. Aggarwal S., Pittenger M.F. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005, 105:1815-1822.
3. Bunnell B.A., Betancourt A.M., Sullivan D.E. New concepts on the immune modulation mediated by mesenchymal stem cells. Stem Cell Research and Therapy 2010, 1:34-41.
4. Carrade D.D., Lame M.W., Kent M.S., Clark K.C., Walker N.J., Borjesson D.L. Comparative analysis of the immunomodulatory properties of equine adult-derived mesenchymal stem cells. Cell Medicine 2012, 4:1-11.
5. Carrade D.D., Affolter V.K., Outerbridge C.A., Watson J.L., Galuppo L.D., Buerchler S., Kumar V., Walker N.J., Borjesson D.L. Intradermal injections of equine allogeneic umbilical cord-derived mesenchymal stem cells are well tolerated and do not elicit immediate or delayed hypersensitivity reactions. Cytotherapy 2011, 13:1180-1192.
6. Carrade D.D., Owens S.D., Galuppo L.D., Vidal M.A., Ferraro G.L., Librach F., Buerchler S., Friedman M.S., Walker N.J., Borjesson D.L. Clinicopathologic findings following intra-articular injection of autologous and allogeneic placentally derived equine mesenchymal stem cells in horses. Cytotherapy 2011, 13:419-430.
7. Carter R.A., Engiles J.B., Megee S.O., Senoo M., Galantino-Homer H.L. Decreased expression of p63, a regulator of epidermal stem cells, in the chronic laminitic equine hoof. Equine Veterinary Journal 2011, 43:543-551.
8. Clegg P.D., Pinchbeck G.L. Evidence-based medicine and stem cell therapy: How do we know such technologies are safe and efficacious?. The Veterinary Clinics of North America: Equine Practice 2011, 27:373-382.
9. Crovace A., Lacitignola L., Rossi G., Francioso E. Histological and immunohistochemical evaluation of autologous cultured bone marrow mesenchymal stem cells and bone marrow mononucleated cells in collagenase-induced tendinitis of equine superficial digital flexor tendon. Veterinary Medicine International 2010, 10.4061/2010/250978.
10. de Mattos Carvalho A., Alves A.L., Golim M.A., Moroz A., Hussni C.A., de Oliveira P.G., Deffune E. Isolation and immunophenotypic characterization of mesenchymal stem cells derived from equine species adipose tissue. Veterinary Immunology and Immunopathology 2009, 132:303-306.
11. Dyson S.J. Medical management of superficial digital flexor tendonitis: A comparative study in 219 horses (1992-2000). Equine Veterinary Journal 2004, 36:415-419.
12. Ferris, D.J., Frisbie, D.D., Kisiday, J.D., McIlwraith, C.W., Hague, B.A., Major, M.D., Schneider, R.K., Zubrod, C.J., Kawcak, C.E., Goodrich, L.R., 2013. Clinical follow-up of thirty-three horses treated for stifle injury with bone marrow derived mesenchymal stem cells intra-articularly. Veterinary Surgery, in press.
13. Fortier L.A., Mohammed H.O., Lust G., Nixon A.J. Insulin-like growth factor-I enhances cell-based repair of articular cartilage. The Journal of Bone and Joint Surgery: British 2002, 84:276-288.
14. Fortier L.A., Potter H.G., Rickey E.J., Schnabel L.V., Foo L.F., Chong L.R., Stokol T., Cheetham J., Nixon A.J. Concentrated bone marrow aspirate improves full-thickness cartilage repair compared with microfracture in the equine model. The Journal of Bone and Joint Surgery: American 2010, 92:1927-1937.
15. Fortier L.A., Travis A.J. Stem cells in veterinary medicine. Stem cell Research and Therapy 2011, 2:9-15.
16. Frisbie D.D., Al-Sobayil F., Billinghurst R.C., Kawcak C.E., McIlwraith C.W. Changes in synovial fluid and serum biomarkers with exercise and early osteoarthritis in horses. Osteoarthritis and Cartilage/OARS, Osteoarthritis Research Society 2008, 16:1196-1204.
17. Frisbie D.D., Kisiday J.D., Kawcak C.E., Werpy N.M., McIlwraith C.W. Evaluation of adipose-derived stromal vascular fraction or bone marrow-derived mesenchymal stem cells for treatment of osteoarthritis. Journal of Orthopaedic Research 2009, 27:1675-1680.
18. Frisbie D.D., Smith R.K. Clinical update on the use of mesenchymal stem cells in equine orthopaedics. Equine Veterinary Journal 2010, 42:86-89.
19. Frisbie D.D., Stewart M.C. Cell-based therapies for equine joint disease. The Veterinary Clinics of North America: Equine Practice 2011, 27:335-349.
20. Godwin E.E., Young N.J., Dudhia J., Beamish I.C., Smith R.K. Implantation of bone marrow-derived mesenchymal stem cells demonstrates improved outcome in horses with overstrain injury of the superficial digital flexor tendon. Equine Veterinary Journal 2012, 44:25-32.
21. Gutierrez-Nibeyro S.D. Commercial cell-based therapies for musculoskeletal injuries in horses. Veterinary Clinics of North America: Equine Practice 2011, 27:363-371.
22. Iacono E., Brunori L., Pirrone A., Pagliaro P.P., Ricci F., Tazzari P.L., Merlo B. Isolation, characterization and differentiation of mesenchymal stem cells from amniotic fluid, umbilical cord blood and Wharton's jelly in the horse. Reproduction 2012, 143:455-468.
23. Koch T.G., Heerkens T., Thomsen P.D., Betts D.H. Isolation of mesenchymal stem cells from equine umbilical cord blood. BMC Biotechnology 2007, 7:26.
24. Koch T.G., Thomsen P.D., Betts D.H. Improved isolation protocol for equine cord blood-derived mesenchymal stromal cells. Cytotherapy 2009, 11:443-447.
25. Kol A., Walker N.J., Galuppo L.D., Clark K.C., Buerchler S., Bernanke A., Borjesson D.L. Autologous point-of-care cellular therapies variably induce equine mesenchymal stem cell migration, proliferation and cytokine expression. Equine Veterinary Journal 2013, 45:193-198.
26. McIlwraith C.W., Frisbie D.D., Rodkey W.G., Kisiday J.D., Werpy N.M., Kawcak C.E., Steadman J.R. Evaluation of intra-articular mesenchymal stem cells to augment healing of microfractured chondral defects. Arthroscopy 2011, 27:1552-1561.
27. Nobert K.M. The regulation of veterinary regenerative medicine and the potential impact of such regulation on clinicians and firms commercializing these treatments. Veterinary Clinics of North America: Equine Practice 2011, 27:383-391.
28. O'Meara B., Bladon B., Parkin T.D., Fraser B., Lischer C.J. An investigation of the relationship between race performance and superficial digital flexor tendonitis in the Thoroughbred racehorse. Equine Veterinary Journal 2010, 42:322-326.
29. Ortved K.F., Nixon A.J., Mohammed H.O., Fortier L.A. Treatment of subchondral cystic lesions of the medial femoral condyle of mature horses with growth factor enhanced chondrocyte grafts: A retrospective study of 49 cases. Equine Veterinary Journal 2012, 44:606-613.
30. Owens S.D., Burges J., Johns J.L., Carrade D.D., Galuppo L.D., Librach F., Borjesson D.L. Processing of equine bone marrow using the automated MarrowXpress System: RBC depletion, volume reduction, and mononuclear cell recovery. Veterinary Clinical Pathology/American Society for Veterinary Clinical Pathology 2011, 40:444-449.
31. Pacini S., Spinabella S., Trombi L., Fazzi R., Galimberti S., Dini F., Carlucci F., Petrini M. Suspension of bone marrow-derived undifferentiated mesenchymal stromal cells for repair of superficial digital flexor tendon in race horses. Tissue Engineering 2007, 13:2949-2955.
32. Pascucci L., Curina G., Mercati F., Marini C., Dall'Aglio C., Paternesi B., Ceccarelli P. Flow cytometric characterization of culture expanded multipotent mesenchymal stromal cells (MSCs) from horse adipose tissue: Towards the definition of minimal stemness criteria. Veterinary Immunology and Immunopathology 2011, 144:499-506.
33. Peroni J.F., Borjesson D.L. Anti-inflammatory and immunomodulatory activities of stem cells. The Veterinary Clinics of North America: Equine Practice 2011, 27:351-362.
34. Prockop D.J., Oh J.Y. Mesenchymal stem/stromal cells (MSCs): Role as guardians of inflammation. Molecular Therapy: The Journal of the American Society of Gene Therapy 2012, 20:14-20.
35. Raabe O., Shell K., Wurtz A., Reich C.M., Wenisch S., Arnhold S. Further insights into the characterization of equine adipose tissue-derived mesenchymal stem cells. Veterinary Research Communications 2011, 35:355-365.
36. Schnabel L.V., Lynch M.E., van der Meulen M.C., Yeager A.E., Kornatowski M.A., Nixon A.J. Mesenchymal stem cells and insulin-like growth factor-I gene-enhanced mesenchymal stem cells improve structural aspects of healing in equine flexor digitorum superficialis tendons. Journal of Orthopaedic Research 2009, 27:1392-1398.
37. Smith R.K. Mesenchymal stem cell therapy for equine tendinopathy. Disability and Rehabilitation 2008, 30:1752-1758.
38. Smith R.K., Korda M., Blunn G.W., Goodship A.E. Isolation and implantation of autologous equine mesenchymal stem cells from bone marrow into the superficial digital flexor tendon as a potential novel treatment. Equine Veterinary Journal 2003, 35:99-102.
39. Sole A., Spriet M., Galuppo L.D., Padgett K.A., Borjesson D.L., Wisner E.R., Brosnan R.J., Vidal M.A. Scintigraphic evaluation of intra-arterial and intravenous regional limb perfusion of allogeneic bone marrow-derived mesenchymal stem cells in the normal equine distal limb using (99 m) Tc-HMPAO. Equine Veterinary Journal 2012, 44:594-599.
40. Stewart M.C. Cell-based therapies: Current issues and future directions. Veterinary Clinics of North America: Equine Practice 2011, 27:393-399.
41. Taylor S.E., Clegg P.D. Collection and propagation methods for mesenchymal stromal cells. The Veterinary Clinics of North America: Equine Practice 2011, 27:263-274.
42. Vidal M.A., Kilroy G.E., Lopez M.J., Johnson J.R., Moore R.M., Gimble J.M. Characterization of equine adipose tissue-derived stromal cells: Adipogenic and osteogenic capacity and comparison with bone marrow-derived mesenchymal stromal cells. Veterinary Surgery 2007, 36:613-622.
43. Vidal M.A., Walker N.J., Napoli E., Borjesson D.L. Evaluation of senescence in mesenchymal stem cells isolated from equine bone marrow, adipose tissue, and umbilical cord tissue. Stem Cells and Development 2012, 21:273-283.
44. Violini S., Gorni C., Pisani L.F., Ramelli P., Caniatti M., Mariani P. Isolation and differentiation potential of an equine amnion-derived stromal cell line. Cytotechnology 2012, 64:1-7.
45. Waterman R.S., Tomchuck S.L., Henkle S.L., Betancourt A.M. A new mesenchymal stem cell (MSC) paradigm: Polarization into a pro-inflammatory MSC1 or an Immunosuppressive MSC2 phenotype. PLoS ONE 2010, 5:e10088.
46. Watts A.E., Yeager A.E., Kopyov O.V., Nixon A.J. Fetal derived embryonic-like stem cells improve healing in a large animal flexor tendonitis model. Stem Cell Research and Therapy 2011, 2:4-15.
47. Wilke M.M., Nydam D.V., Nixon A.J. Enhanced early chondrogenesis in articular defects following arthroscopic mesenchymal stem cell implantation in an equine model. Journal of Orthopaedic Research 2007, 25:913-925.
48. Yingling G.L., Nobert K.M. Regulatory considerations related to stem cell treatment in horses. Journal of the American Veterinary Medical Association 2008, 232:1657-1661.